版本:
中国

BRIEF-Veru Healthcare plans to advance its veru-944 into phase 2 clinical trial

May 24 Female Health Co:

* Veru Healthcare - plans to advance its veru-944 into phase 2 clinical trial for treatment of hot flashes in men receiving hormone therapy for prostate cancer

* Veru Healthcare -plan to commence phase 2 trial as soon as possible, and if successful, we expect to begin our phase 3 trial in second half of 2018

* Veru Healthcare - decision to advance the drug followed a pre-investigational new drug application meeting with U.S. FDA Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐